Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2007, p. 2611-2614, Vol. 51, No. 7
0066-4804/07/$08.00+0 doi:10.1128/AAC.00838-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Characterization of an Integron Carrying blaIMP-1 and a New Aminoglycoside Resistance Gene, aac(6')-31, and Its Dissemination among Genetically Unrelated Clinical Isolates in a Brazilian Hospital
Rodrigo E. Mendes,1*
Mariana Castanheira,1
Mark A. Toleman,2
Helio S. Sader,1,3
Ronald N. Jones,3,4 and
Timothy R. Walsh2
Laboratório Especial de Microbiologia Clínica and Laboratório ALERTA, Division of Infectious Disease, Federal University of São Paulo, São Paulo, Brazil,1
Department of Pathology and Microbiology, University of Bristol, Bristol, United Kingdom,2
JMI Laboratories, North Liberty, Iowa,3
Tufts University School of Medicine, Boston, Massachusetts4
Received 10 July 2006/
Returned for modification 14 October 2006/
Accepted 19 April 2007

ABSTRACT
Seven
blaIMP-1-harboring
Acinetobacter sp. isolates and one
Pseudomonas putida clinical isolate were recovered from hospitalized
patients. All isolates possessed a class 1 integron, named In86,
carrying the same cassette array [
blaIMP1,
aac(6'
)-31, and
aadA1],
which was plasmid located in five of the isolates. This report
describes the ability of nonfermentative nosocomial pathogens
to acquire and disseminate antimicrobial resistance determinants.

TEXT
Metallo-β-lactamases (MβLs) and aminoglycoside-modifying
enzymes (AgMEs) represent a new challenge to antimicrobial therapy
of nosocomial infections, since they confer phenotypic resistance
to nearly all clinically available β-lactams and aminoglycosides,
respectively (
1). Several MβL and aminoglycoside resistance
genes in nosocomial isolates recovered from Latin American countries
have been described previously (
7,
8,
9); however, there is
limited information regarding the dissemination of these genes
in this region. In the present study, we describe a new
blaIMP-1-carrying
integron that contains a new aminoglycoside resistance gene
and its dissemination among genetically unrelated clinical isolates
recovered from a Brazilian hospital.
As part of the SENTRY Antimicrobial Surveillance Program (12), gram-negative bacilli recovered from Latin American hospitals between March 2001 and April 2003 were tested for antimicrobial susceptibility by reference methods according to standard guidelines (3, 4). Strains showing combined resistance to ceftazidime (MIC,
16 µg/ml), imipenem (MIC,
16 µg/ml), and meropenem (MIC,
16 µg/ml) were routinely screened for MβL genes by standards PCRs (2, 9, 11). Seven Acinetobacter sp. isolates and one Pseudomonas putida clinical isolate recovered from a 600-bed tertiary university hospital located in São Paulo, Brazil, were found to harbor blaIMP-1 and were further evaluated in the present study (Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1. Clinical and antimicrobial profile and molecular information from the clinical isolates harboring blaIMP-1-carrying In86 evaluated in the present study
|
In general, the evaluated isolates showed a decreased susceptibility
or resistance phenotype to mostly all the antimicrobial agents
tested, showing susceptibility only to polymyxin B, and some
isolates also showed susceptibility to quinolones (Table
1).
A genotypic comparison of the
blaIMP-1-harboring
Acinetobacter sp. isolates was performed using the RiboPrinter microbial characterization
system and pulsed field-gel electrophoresis (PFGE), as previous
described (
12).
Acinetobacter sp. isolates 694 and 696 showed
identical PFGE patterns, while isolates 9043 and 695 differed
from each other in less than five bands (similar PFGE patterns),
and they were considered to belong to the same ancestor. The
remaining
Acinetobacter spp. showed distinct PFGE patterns and
were considered to be unrelated (
16). In summary, five different
clones were observed among the seven
Acinetobacter sp. isolates
(Table
1).
The blaIMP-1-containing integrons were amplified by PCR and sequenced using primers targeting the 5' conserved sequences (CS) and 3' CS of class 1 integrons (2, 9). All isolates possessed the same class 1 integron cassette arrangement, designated In86. This integron harbored blaIMP-1 at the first position downstream of the 5' CS, followed by an open reading frame of 519 bp identified as a new AgME gene cassette. This gene, designated aac(6')-31, was followed by another AgME gene cassette, namely, aadA1 (Fig. 1). aac(6')-31 potentially encoded a protein of 173 amino acids (19.1 kDa), which exhibited the highest identity (82.1%) to AAC(6')-Ib' (GenBank accession number CAE48336) (Fig. 2), encoded by the blaIMP-16-carrying Pseudomonas aeruginosa integron isolated from Brasília, Brazil (9), 630 miles from São Paulo, suggesting that these two genes could be derived from a common ancestor.
To evaluate the flanking DNA sequences upstream of In86, these
regions were sequenced using a random primer PCR approach as
previously described (
15). The 5' CS of In86 in the
P. putida isolate contained the integrase gene, which was bound by a Tn
402-like
25-bp IR
i sequence. The DNA sequence upstream of the 25-bp IR
i did not show any homology with previously deposited sequences
in the GenBank database (Fig.
1 and
3). However, all the
Acinetobacter sp. isolates showed the same DNA insertion just downstream of
the In86 integrase gene, which was inserted between the i2 and
i3 19-bp repeats that are usually present in the internal region
of the IR
i (
13) (Fig.
1 and
3). This sequence also did not possess
homology with previously reported DNA sequences. Moreover,
Acinetobacter sp. isolate 501 showed a second DNA insertion just upstream
of the previous one, which was revealed to be a terminal inverted
repeat, IS
1006.1, located 138 bp upstream of the IR
i. IS
1006.1 was closely related to the terminal repeat of IS
26, IS
1006,
IS
1007, IS
1009, and IS
1010 followed by the exact last 39 nucleotides
of the
tnp1006 gene (Fig.
3). This structure showed the highest
identity to a similar region in the
Acinetobacter lwoffii plasmid
pKLH202 (GenBank accession number AJ486857) (
5). These findings
suggest that the integron found in the
P. putida strain was
likely to be the progenitor
blaIMP-1-carrying integron circulating
in this nosocomial environment.
Repeated electroporation and conjugation experiments of putative
plasmid DNA extracts from the
blaIMP-1-containing strains, performed
as previously described (
9), failed. Despite several preparations,
the presence of plasmid DNA was not observed in
P. putida and
in
Acinetobacter sp. isolate 5227, suggesting a chromosomal
location. The remaining isolates showed several plasmids (data
not shown), which were recognized by a
blaIMP-1-specific probe
in a Southern blot experiment (
14), suggesting that In86 was
plasmid located in those isolates (data not shown). The
blaIMP-1 probe recognized plasmids showing similar sizes, apart from
Acinetobacter sp. isolate 501, which seemed to possess a slightly
smaller
blaIMP-1-carrying DNA plasmid. These hybridization profiles
were in agreement with the sequencing results, which showed
an identical structure downstream of the integrase gene in those
Acinetobacter sp. isolates except for
Acinetobacter sp. isolate
501, suggesting a distinct genetic locus in the latter strain.
To determine the functionality of aac(6')-31, the gene was amplified by PCR and ligated into a pPCRScriptCam SK(+) vector to construct the recombinant plasmid pIMPAR-31 as previously described (9). This plasmid was subsequently transferred into Escherichia coli DH5
cells, and the recombinant strain was tested for susceptibility against several aminoglycosides (Table 2). aac(6')-31 expressed in E. coli DH5
cells conferred decreased susceptibility to all aminoglycosides evaluated, including gentamicin, tobramycin, kanamycin, amikacin, neomycin, netilmicin, sisomicin, and isepamicin. MICs were 8- to
32-fold higher than those for E. coli DH5
(Table 2). This phenotype has not been described previously but was observed only when different AgME genes were expressed in combinations. This suggests that the expression of aac(6')-31 may be sufficient to confer resistance to all clinically available aminoglycosides, and this gene may gradually replace other aac(6') family genes commonly found among nonfermentative pathogens. A similar situation was previously observed among bacterial strains recovered from Turkey (10).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Aminoglycoside susceptibility profiles of E. coli DH5 -harboring recombinant plasmid pIMPAR-31 and the recipient strain E. coli DH5
|
The presence of five genetically unrelated
Acinetobacter sp.
strains and one
P. putida strain, sharing a common
blaIMP-1-carrying
integron during the study period, shows the ability of nonfermentative
nosocomial strains to acquire and subsequently spread antimicrobial
resistance determinants. This may be the reason for the continuing
recovery of
blaIMP-1-harboring
P. aeruginosa and
Acinetobacter sp. strains in this hospital.
Nucleotide sequence accession numbers.
The nucleotide sequences of the blaIMP-1-containing integron described in this paper have been submitted to the EMBL/GenBank/DNA Data Bank of Japan sequence databases and assigned the accession numbers AM283489 (P. putida), AM283490 (Acinetobacter baumannii strain 501), and AJ640197 (Acinetobacter sp. strains 695, 696, 5227, 9043, and 5248).

ACKNOWLEDGMENTS
We thank Rosa Maria Silva and Renata Cristina Picão for
their excellent technical contribution to the manuscript.
H. S. Sader and R. N. Jones have received research/education grants in the last 3 years from AB BIODISK, Abbott, AlamX, Arpida, AstraZeneca, Avexa, Basilea, Bayer, Becton Dickinson, Beninger-Ingelheim, bioMerieux, Bristol-Myers Squibb, Cadence, Cerexa, Chiron, Cognigen, Cubist, Daiichi, Elan, Elanco, Enanta, GlaxoSmithKline, Intrabiotics, Johnson & Johnson, LG Chemicals, Merck, Micrologix, Novartis, Optimer, Ordway, Oscient, Osmotics, Peninsula, Pfizer, Replidyne, Schering-Plough, Sequoia, Serenex, Shionogi, Theravance, TREK Diagnostics, Vicuron, and Wyeth.

FOOTNOTES
* Corresponding author. Mailing address: Special Clinical Microbiology Laboratory, Division of Infectious Diseases, Federal University of São Paulo, Rua Leandro Dupret 188, São Paulo CEP 04025-010, Brazil. Phone: (55-11) 5081-2819. Fax: (55-11) 5571-5180. E-mail:
rodrigo.mendes{at}lemc.com.br 
Published ahead of print on 30 April 2007. 

REFERENCES
1 - Bush, K., and G. H. Miller. 1998. Bacterial enzymatic resistance: β-lactamases and aminoglycoside-modifying enzymes. Curr. Opin. Microbiol. 1:509-515.[CrossRef][Medline]
2 - Castanheira, M., M. A. Toleman, R. N. Jones, F. J. Schmidt, and T. R. Walsh. 2004. Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother. 48:4654-4661.[Abstract/Free Full Text]
3 - Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A7. CLSI, Wayne, PA.
4 - Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing, 16th informational supplement M100-S16. CLSI, Wayne, PA.
5 - Kholodii, G., S. Mindlin, Z. Gorlenko, M. Petrova, J. Hobman, and V. Nikiforov. 2004. Translocation of transposition-deficient (TndPKLH2-like) transposons in the natural environment: mechanistic insights from the study of adjacent DNA sequences. Microbiology 150:979-992.[Abstract/Free Full Text]
6 - Lambert, T., M. C. Ploy, and P. Courvalin. 1994. A spontaneous point mutation in the aac(6')-Ib' gene results in altered substrate specificity of aminoglycoside 6'-N-acetyltransferase of a Pseudomonas fluorescens strain. FEMS Microbiol. Lett. 115:297-304.[Medline]
7 - Lincopan, N., J. A. McCulloch, C. Reinert, V. C. Cassettari, A. C. Gales, and E. M. Mamizuka. 2005. First isolation of metallo-β-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J. Clin. Microbiol. 43:516-519.[Abstract/Free Full Text]
8 - Mendes, R. E., M. Castanheira, P. Garcia, M. Guzman, M. A. Toleman, T. R. Walsh, and R. N. Jones. 2004. First isolation of blaVIM-2 in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:1433-1434.[Free Full Text]
9 - Mendes, R. E., M. A. Toleman, J. Ribeiro, H. S. Sader, R. N. Jones, and T. R. Walsh. 2004. Integron carrying a novel metallo-β-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:4693-4702.[Abstract/Free Full Text]
10 - Over, U., D. Gur, S. Unal, and G. H. Miller. 2001. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin. Microbiol. Infect. 7:470-478.[CrossRef][Medline]
11 - Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.[Abstract/Free Full Text]
12 - Ribeiro, J., R. E. Mendes, R. Domingos, E. Franca, S. Silbert, R. N. Jones, and H. S. Sader. 2006. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program. J. Chemother. 18:461-467.[Medline]
13 - Riccio, M. L., L. Pallecchi, J. D. Docquier, S. Cresti, M. R. Catania, L. Pagani, C. Lagatolla, G. Cornaglia, R. Fontana, and G. M. Rossolini. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-β-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110.[Abstract/Free Full Text]
14 - Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15 - Sorensen, A. B., M. Duch, P. Jorgensen, and F. S. Pedersen. 1993. Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J. Virol. 67:7118-7124.[Abstract/Free Full Text]
16 - Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Free Full Text]
Antimicrobial Agents and Chemotherapy, July 2007, p. 2611-2614, Vol. 51, No. 7
0066-4804/07/$08.00+0 doi:10.1128/AAC.00838-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Gillings, M. R., Labbate, M., Sajjad, A., Giguere, N. J., Holley, M. P., Stokes, H. W.
(2009). Mobilization of a Tn402-Like Class 1 Integron with a Novel Cassette Array via Flanking Miniature Inverted-Repeat Transposable Element-Like Structures. Appl. Environ. Microbiol.
75: 6002-6004
[Abstract]
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Deshpande, L. M., Jones, R. N.
(2009). Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother.
53: 843-844
[Full Text]
-
Bennett, J. W., Herrera, M. L., Lewis, J. S. II, Wickes, B. W., Jorgensen, J. H.
(2009). KPC-2-Producing Enterobacter cloacae and Pseudomonas putida Coinfection in a Liver Transplant Recipient. Antimicrob. Agents Chemother.
53: 292-294
[Abstract]
[Full Text]
-
Juan, C., Beceiro, A., Gutierrez, O., Alberti, S., Garau, M., Perez, J. L., Bou, G., Oliver, A.
(2008). Characterization of the New Metallo-{beta}-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain. Antimicrob. Agents Chemother.
52: 3589-3596
[Abstract]
[Full Text]
-
Gutierrez, O., Juan, C., Cercenado, E., Navarro, F., Bouza, E., Coll, P., Perez, J. L., Oliver, A.
(2007). Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals. Antimicrob. Agents Chemother.
51: 4329-4335
[Abstract]
[Full Text]